EUROPEAN ASSOCIATION OF HAEMOPHILIA AND ALLIED D..

12th Annual Congress of EAHAD

 

6-8 February 2019 Prague
Close
N. Poster
Poster title
Applicant name
Status
  26-P THE EFFECT OF ANTI-VON WILLEBRAND FACTOR IMMUNOGLOBULIN ON ASSAYS OF VON WILLEBRAND FACTOR: CASE REPORTS Annette Bowyer Received Received
  27-P THE EFFECT OF EMICIZUMAB ON ASSAYS OF FACTOR VIII ACTIVITY IN SEVERE HAEMOPHILIA A PATIENTS AND ARTIFICIALLY SPIKED PLASMA Annette Bowyer Received Received
  28-P THE SOCIOECONOMIC BURDEN OF MODERATE AND SEVERE HAEMOPHILIA IN CHINA: A FEASIBILITY STUDY Antony Martin Received Received
  35-P MEASURING rFIX-Fc WITH 19 DIFFERENT COMBINATIONS COAGULOMETERS - REAGENTS : A SINGLE CENTER STUDY Aurélien Lebreton Received Received
  45-P OVER TWO DECADES OF ORTHOPAEDIC SURGERY IN PATIENTS WITH INHIBITORS QUANTIFYING THE COMPLICATION OF BLEEDING Borna Guevel Received Received
  59-P ASSESSMENT OF CLOTTING ACTIVITY OF RECOMBINANT FIXFC FUSION PROTEIN IN FRENCH HAEMOSTASIS LABORATORIES Caroline MARTINEZ Received Received
  62-P USING PATIENT-LEVEL SIMULATION TO MODEL PATIENT-CENTRIC OUTCOMES IN THE ADVENT OF GENE THERAPY IN SEVERE HAEMOPHILIA A Charlotte CAMP Received Received
  64-P THE ADVANCE STUDY: A LONGITUDINAL STUDY OF AGE-RELATED COMORBIDITIES IN PEOPLE WITH HAEMOPHILIA BASELINE INTERIM RESULTS AFTER COMPLETED INCLUSION Christian Qvigstad Received Received
  65-P CLINICAL EFFICACY OF DIFFERENT TREATMENT OPTIONS FOR HAEMOPHILIA: PITFALLS OF COMPARING ANNUAL BLEEDING RATES Christine Keipert Received Received
  68-P A SIMPLE FUNCTIONAL MOBILITY ASSESSMENT TOOL FOR USE IN CLINICAL PRACTICE OR REAL-LIFE STUDIES WITH HEMOPHILIA PATIENTS: STEP 1, DEVELOPMENT OF THE QUESTIONNAIRE (FRENCH VERSION) Corinne GANDOSSI Received Received
  79-P IMPACT OF ACUTE AND CHRONIC PAIN ON THE EQ-5D: INSIGHTS FROM THE PROBE STUDY Declan Noone Received Received
  80-P PREDICTORS FOR ACUTE AND CHRONIC PAIN IN PATIENTS WITH SEVERE HAEMOPHILIA IN THE PROBE COHORT Declan Noone Received Received
  86-P THE WFH WORLD BLEEDING DISORDERS REGISTRY Mayss Naccache Received Received
  111-P THE WORKING GROUP SETTING UP THE EAHAD PSYCHOSOCIAL COMMITTEE Lotte Haverman Received Received
  113-P TOWARDS EVALUATION OF HEMOPHILIA THERAPIES IN THE NETHERLANDS: A NATIONWIDE PATIENT REGISTRY AND DIGITAL INFUSION LOG. Geertje Goedhart Received Received
  122-P TELEMEDICINE AND ITS TOOLS TO IMPROVE REHABILITATION IN HEMOPHILIA Valentina Begnozzi Received Received
  125-P CORRECTING HEMOPHILIA A USING HUMAN FVIII PRODUCED IN VIVO BY AFIBROMER SHIELDED ENGINEERED ALLOGENEIC CELLS David Peritt Received Received
  126-P MONITORING OF EMICIZUMAB (ACE910): COMPARISON BETWEEN CLOTTING AND CHROMOGENIC ASSAY Halet Trkantoz Received Received
  151-P Using individual pharmacokinetic parameters on octocog alfa to predict individual pharmacokinetic parameters on efmoroctocog alfa in persons with hemophilia A Jacky Yu Received Received
  154-P PROBLEM JOINT A MORE PATIENT RELEVANT DEFINITION FOR JOINT MORBIDITY IN HAEMOPHILIA Tom BURKE Received Received
  168-P COMPARISON OF PATIENT EXPERIENCE (PE) AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PEOPLE WITH SEVERE FACTOR IX DEFICIENCY BEFORE AND AFTER AN EN-MASSE SWITCH TO AN EXTENDED HALF-LIFE (EHL) FACTOR IX (FIX) CONCENTRATE. Kate Johnston Received Received
  169-P THROMBOPROPHYLAXIS AND SURGICAL OUTCOMES IN PEOPLE WITH HAEMOPHILIA UNDERGOING ORTHOPAEDIC SURGERY: ESTABLISHING A LOCAL STANDARD OF CARE Kate Johnston Received Received
  194-P ANALYSIS OF THE EDUCATION AND WORK SITUATIONS IN ADULT PATIENTS WITH HEMOPHILIA. Maria Sol Cruz Received Received
  195-P UPDATE TO THE MANUAL ON DENTAL MANAGEMENT IN HEMOPHILIA AND VON WILLEBRAND PATIENTS Maria Sol Cruz Received Received
  204-P PART-TIME EMPLOYMENT AND EARLY RETIREMENT IN PEOPLE WITH SEVERE HAEMOPHILIA: INSIGHTS FROM THE PROBE STUDY Mark Skinner Received Received
  207-P IN THE PRESENCE OF EMICIZUMAB, FACTOR VIIA ACTIVATION OF FACTOR IX CONTRIBUTES TO FACTOR XA GENERATION. Maureane Hoffman Received Received
  213-P INSIGHTS INTO THE EVOLUTION OF HAEMOPHILIAC ARTHROPATHY: THE IRISH PERSONALISED APPROACH TO THE TREATMENT OF HAEMOPHILIA (IPATH) STUDY. MICHELLE LAVIN Received Received
  220-P USE OF VON WILLEBRAND FACTOR CONCENTRATE IN INHERITED VON WILLEBRAND DISEASE. HOW OFTEN IS IT USEFUL TO ADD FACTOR VIII ? Nicolas Drillaud Received Received
  235-P EVALUATION OF HEMORRHAGE RISK IN HAEMOPHILIAC A PATIENTS WITH AND WITHOUT INHIBITOR BY MEANS OF CALIBRATED AUTOMATIC THROMBOGRAM (CAT) Laura Tomás Menor Received Received
  236-P EXPOSURE DEGREE TO RECOMBINANT FACTORS AND BLEEDING EPISODES IN PATIENTS WITH SEVERE HAEMOPHILIA A IN A SINGLE HAEMOPHILIA CENTRE LAURA TOMÁS Received Received
  237-P MUSCULOSKELETAL ULTRASOUND EVALUATION OF EXTRARTICULAR EFFUSIONS IN HAEMOPHILIC PEDIATRIC PATIENTS Alejandra Patricia Nally Received Received
  241-P DILUTIONAL LINEARITY DEMONSTRATED OVER THE WHOLE MEASURING RANGE FOR TWO EXTENDED HALF LIFE RECOMBINANT FACTOR IX (EHL-RFIX) PRODUCTS WITH A CHROMOGENIC FACTOR IX KIT. Per Rosen Received Received
  249-P TREATMENT PATTERNS, DETERMINANTS AND OUTCOMES OF HEMOPHILIA: RESULTS FROM A MULTINATIONAL SURVEY Pronabesh DasMahapatra Received Received
  257-P AN INTRODUCTION TO CVESS: THE COST OF VON WILLEBRAND DISEASE IN EUROPE- A SOCIOECONOMIC STUDY Rosa Willock Received Received
  267-P GOING DIGITAL WITH CLINICAL TREATMENT PLANS Sarah Mangles Received Received
  268-P THE CARES STUDY FOCUS GROUPS- HAEMOPHILIA CARRIERS EXPERIENCE STUDY: LIFE CHOICES, PSYCHOSOCIAL NEEDS AND PARENTING Sarah Mangles Received Received
  269-P RESOURCE USE AND COSTS OF HEMOPHILIA A PATIENTS IN THE NETHERLANDS Tam VO Received Received
  275-P CONGENITAL FACTOR XIII DEFICIENCY : DESCRIPTION OF THE FRENCH COHORT FROM THE FRANCECOAG NETWORK. Séverine Bouttefroy Received Received
  284-P REVIEW OF HAEMOPHILIA CARE IN INDIA Stefan Bosbach Received Received
  285-P THROMBIN GENERATION ASSAY TO GUIDE REPLACEMENT THERAPY IN PATIENTS WITH FACTOR XI DEFICIENCY UNDERGOING ELECTIVE SURGERY Stéphanie Désage Received Received
  293-P ASSOCIATED IMPACT OF TREATMENT ADHERENCE ON HEALTH-RELATED QUALITY OF LIFE AND WORK IMPAIRMENT IN SEVERE HAEMOPHILIA A Charlotte CAMP Received Received
  294-P AN INTRODUCTION TO THE COST OF HAEMOPHILIA ACROSS EUROPE - A SOCIOECONOMIC SURVEY (CHESS): PAEDIATRICS STUDY Tom Burke Received Received
  295-P KEY FINDINGS FROM AN EXPERT VALIDATION WORKSHOP TO ESTABLISH AN APPROPRIATE MODELLING FRAMEWORK IN SEVERE HAEMOPHILIA A Charlotte CAMP Received Received
  296-P USE OF PHARMACOKINETICS-PHARMACODYNAMICS MODELING AND SIMULATION TO SUPPORT EARLY PHASE DOSE SELECTION FOR PF-06741086, AN ANTI-TFPI MONOCLONAL ANTIBODY Aileen Echeverry Received Received
  298-P EXERGAMES FOR HOME REHABILITATION IN CHILDREN WITH HEMOPHILIA Valentina Begnozzi Received Received
  300-P IMPLEMENTATION OF A WEB-BASED PLATFORM FOR JOINT MONITORING IN PATIENTS WITH HAEMOPHILIA IN NHEMO DATABASE VALERIE HORVAIS Received Received
  302-P LOW DOZE PROPHYLAXIS THERAPY IN SEVERE PEDIATRIC HEMOPHILIA A PATIENTS Vijay Shah Received Received
  303-P AVOIDING ACCUMULATION OF FVIII WHEN TREATING VWD PATIENTS WITH NORMAL BASELINE FVIII LEVELS BY USING A HIGH RATIO VON WILLEBRAND CONCENTRATE Vincent Hortensius Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
11:45
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

12th Annual Congress of EAHAD

 

6-8 February 2019 Prague
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 06/02/2019 TO 06/02/2019
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert